20:0 PC:Chol (70:30) Liposomes (CAT#: LDLY-0123-LY126)

Description
The liposomes made from saturated phosphatidylcholine (PC) lipids with cholesterol.
Lipid Composition
20:0 PC: 70M
Cholesterol: 30M
Applications
Control liposomes, Membrane biology
Format
Liquid
Concentration
10mg/mL
Hydration Solution
PBS, pH 7.4
External Solution
PBS, pH 7.4
Storage
2°C - 8°C (do not freeze)
Size
100 nm
Shelf Life
6 months
Quantity
5mL (available in lyophilized powder)
Download
DataSheet MSDS
FAQs Customer Reviews Related Sections
  1. What are 20:0 PC:Chol (70:30) liposomes?

    20:0 PC:Chol (70:30) liposomes are vesicles composed of a 70:30 molar ratio of 20:0 phosphatidylcholine (PC) to cholesterol. The 20:0 PC refers to a fully saturated PC, which contributes to the rigidity and stability of the liposome membrane.

  2. Why is cholesterol included in the 20:0 PC:Chol (70:30) liposome formulation?

    Cholesterol is incorporated to enhance membrane stability, reduce permeability, and increase the structural integrity of the liposomes. This addition is crucial for prolonging the circulation time of liposomes in the bloodstream and improving the encapsulation efficiency of therapeutic agents.

  3. What are the primary applications of 20:0 PC:Chol (70:30) liposomes in research?

    These liposomes are frequently used in drug delivery systems, particularly for the delivery of hydrophobic drugs and small molecules. Their enhanced stability makes them suitable for targeting specific tissues or cells in therapeutic applications.

  4. What advantages do 20:0 PC:Chol (70:30) liposomes offer over other liposomal formulations?

    The use of fully saturated PC like 20:0 PC increases the rigidity of the liposome, which is beneficial for maintaining the structure under physiological conditions and during storage. This rigidity can help in sustaining drug release at a controlled rate.

  5. How are 20:0 PC:Chol (70:30) liposomes typically prepared?

    They are usually prepared using techniques such as thin-film hydration followed by extrusion or sonication to ensure a uniform size distribution. This preparation method helps achieve desired size specifications and encapsulation efficiencies.

  • Enhanced Drug Stability
    Creative Biolabs' 20:0 PC:Chol (70:30) liposomes offer enhanced drug stability, critical for our long-term pharmacological studies.
  • Superior in Viscosity-Controlled Delivery
    These liposomes are superior for viscosity-controlled delivery, ensuring consistent therapeutic dosing in our clinical research.
  • Creative Biolabs' Robust Liposome Composition
    The robust composition of 20:0 PC:Chol (70:30) by Creative Biolabs provides exceptional membrane rigidity, improving our encapsulation efficiency.
  • Optimized for Targeted Delivery
    These liposomes are perfectly optimized for targeted delivery, enhancing the efficacy of active compounds in hard-to-reach tissues.
  • High Purity for Sensitive Applications
    The high purity of these liposomes makes them ideal for our sensitive biomedical applications, ensuring minimal batch-to-batch variability.

Click the button below to contact us or submit your feedback about this product.

For Research Use Only. Not For Clinical Use

Online Inquiry